Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Agrees To Limit Distribution, Promotion Of Crestor 40 Mg

Executive Summary

AstraZeneca has agreed to an unusual distribution system for Crestor to limit use of the 40 mg dose of the statin
Advertisement

Related Content

Crestor DTC Ads To Resume Following Safety Labeling Update
AstraZeneca Crestor Defense Minimizes Risk Of High Dose, FDA Says
Crestor European Label Changes Prompt FDA Public Health Advisory
AstraZeneca Defends Crestor; Public Citizen Renews Call For Withdrawal
FDA “Case Studies” On Dosing Problems Include Lotronex, Crestor
AstraZeneca Crestor 10 Mg Starting Dose Priced At 12% Discount To Lipitor
AstraZeneca Crestor 10 Mg Starting Dose Priced At 12% Discount To Lipitor
AstraZeneca Crestor 10 mg Fixed Starting Dose Supported By Committee
AstraZeneca Crestor Plan: Drop 80 Mg, Submit Lower-Dose Data In Q1
Baycol Withdrawal Gives Boost To Pravachol; Will Crestor NDA Be Affected?
Advertisement
UsernamePublicRestriction

Register

PS042306

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel